Centrus Energy Corp. (LEU) Stock Analysis

Centrus Energy’s primary competitive advantage is its unique regulatory position: it is the only U.S.-owned and operated company licensed by the Nuclear Regulatory Commission to produce High-Assay, Low-Enriched Uranium (HALEU), a fuel required for next-generation nuclear reactors. This regulatory moat is reinforced by U.S. policy, which is phasing out Russian uranium imports by 2028 and mandates domestic sourcing for national security applications. In contrast, global rivals such as Urenco (Anglo-Dutch-German consortium) and France’s Orano lack U.S. ownership and are restricted from supplying certain U.S. government contracts.

Centrus also benefits from first-mover status in commercial-scale HALEU production, with operational capacity at its Piketon, Ohio facility and a $900 million Department of Energy (DOE) contract to expand further. Its $3.9 billion contracted backlog and $1.9 billion cash position provide financial stability and visibility, supporting large-scale expansion and insulating against near-term market volatility.

Vertically integrated manufacturing and a domestic supply chain reduce geopolitical and supply chain risks, a key differentiator versus competitors reliant on foreign technology or imports. While Centrus lacks the scale of Urenco or Orano, its exclusive U.S. license, government relationships, and technical expertise create a durable, state-backed moat. The main threat is execution risk—delays or cost overruns could erode its lead before competitors scale up HALEU production.